The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation

Therapeutics that block tumor necrosis factor (TNF), and thus activation of TNF receptor 1 (TNFR1) and TNFR2, are clinically used to treat inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease and psoriasis. However, TNFR1 and TNFR2 work antithetically to balance immune resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, Fabian, Williams, Sarah K., John, Katharina, Huber, Carina, Vaslin, Camille, Zanker, Henri, Fairless, Richard, Pichi, Kira, Marhenke, Silke, Vogel, Arndt, Dhaen, Marie-Ann, Herrmann, Stefanie, Herrmann, Andreas, Pfizenmaier, Klaus, Bantel, Heike, Diem, Ricarda, Kontermann, Roland E., Fischer, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294390/
https://www.ncbi.nlm.nih.gov/pubmed/34305946
http://dx.doi.org/10.3389/fimmu.2021.705485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294390/
https://www.ncbi.nlm.nih.gov/pubmed/34305946
http://dx.doi.org/10.3389/fimmu.2021.705485

Ejemplares similares